ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1992

The Effect of 4E-BP1 on Osteoarthritis-Related Gene Expression in TGF-β1-Stimulated Chondrocytes

Mi Hyun Lee, Ju-Ryoung Kim, Hyun Sook Hwang and Hyun Ah Kim, Hallym University Sacred Heart Hospital, Kyunggi-do, Korea, Republic of (South)

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: cartilage and osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, October 23, 2018

Title: Osteoarthritis and Joint Biology – Basic Science Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Initiation of protein synthesis is regulated by a repressor of cap-dependent translation, eukaryotic initiation factor 4E-binding protein 1 (4E-BP1), which prevents eukaryotic initiation factor 4E (eIF4E) from participating in the eukaryotic translation apparatus through its binding to eIF4E. In this study we determined whether the control of translational apparatus activity could have an effect on the expression of transforming growth factor-beta 1 (TGF-β1)-induced catabolic or anabolic genes in primary chondrocytes and be responsible for the pathogenesis of osteoarthritis (OA).

Methods:

Human articular chondrocytes were enzymatically isolated from articular cartilage and cultured in monolayer. The relative levels of mRNA and protein were analyzed by real-time quantitative reverse transcription-polymerase chain reaction and Western blot analysis, respectively. Immunoprecipitation (IP) assay was performed to investigate the binding of 4E-BP1 to eIF4E. The total protein synthesis was measured by flow cytometry using protein synthesis assay kit. 4E-BP1 and mTOR genes were knocked down by transfection with small interfering RNAs (siRNAs).

Results:

The level of 4EBP-1 was significantly higher in human OA cartilage than normal cartilage. TGF-β1 increased total protein synthesis, including aggrecan (ACAN) and collagen type II (Col II), together with activation of Akt/mTOR signaling pathway. IP data demonstrated that TGF-β1 treatment suppressed the interaction of 4E-BP1 and eIF4E. mTOR silencing significantly suppressed ACAN and Col II expressions through decreased level of phosphorylated 4E-BP1 in TGF-β1-treated chondrocytes. On the other hand, 4E-BP1 knockdown promoted total protein synthesis but suppressed Col II and ACAN expressions with decreased expression of Smad2/3 and Smad4 and increased expression of inhibitory Smad6 and Smad7. Furthermore, knockdown of Smad4 suppressed Col II and ACAN expression whereas increased expressions of Col II and ACAN were observed in Smad6- or Smad7-knocked down chondrocytes

Conclusion:

These results demonstrated that TGF-β1-modulated phosphorylation of 4EBP1 plays a role in the expression of Col II and ACAN through alteration of Smad signaling pathway.


Disclosure: M. H. Lee, None; J. R. Kim, None; H. S. Hwang, None; H. A. Kim, None.

To cite this abstract in AMA style:

Lee MH, Kim JR, Hwang HS, Kim HA. The Effect of 4E-BP1 on Osteoarthritis-Related Gene Expression in TGF-β1-Stimulated Chondrocytes [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/the-effect-of-4e-bp1-on-osteoarthritis-related-gene-expression-in-tgf-%ce%b21-stimulated-chondrocytes/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-effect-of-4e-bp1-on-osteoarthritis-related-gene-expression-in-tgf-%ce%b21-stimulated-chondrocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology